Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Rallybio Corporation - Common Stock (NQ:RLYB)

6.800 +0.980 (+16.84%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 146,866
Open 5.800
Bid (Size) 6.610 (100)
Ask (Size) 6.690 (300)
Prev. Close 5.820
Today's Range 5.800 - 6.810
52wk Range 0.2201 - 6.810
Shares Outstanding 37,747,433
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement
From Rallybio Corporation
Via Business Wire
News headline image
Rallybio Announces Reverse Stock Split of Common Stock
From Rallybio Corporation
Via Business Wire

Performance

YTD
+861.4%
+861.4%
1 Month
+962.3%
+962.3%
3 Month
+944.4%
+944.4%
6 Month
+1113.9%
+1113.9%
1 Year
+818.9%
+818.9%

More News

Read More
News headline image
RALLYBIO CORP (NASDAQ:RLYB) Reports Q3 2025 Earnings Beat Fueled by Asset Sale and Advances Clinical Pipeline ↗
Via Chartmill
Topics Earnings
News headline image
Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates
From Rallybio Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
From Rallybio Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
Rallybio Receives $12.5 Million Equity Milestone Payment from Recursion for Advancement of REV102 Program
From Rallybio Corporation
Via Business Wire
News headline image
Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Rallybio Reports Second Quarter 2025 Financial Results and Provides Business Updates
From Rallybio Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Top movers in Tuesday's session ↗
Via Chartmill
News headline image
Most active stocks in Tuesday's session ↗
Via Chartmill
News headline image
Here's Why Shares in Recursion Pharmaceuticals Surged Today ↗
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
What's going on in today's session ↗
Via Chartmill
News headline image
Gapping stocks in Tuesday's session ↗
Via Chartmill
News headline image
Why Is Microcap Rallybio Stock Trading Higher On Tuesday? ↗
Via Benzinga
News headline image
Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals
From Rallybio Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Via Benzinga
News headline image
Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
From Rallybio Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga

Frequently Asked Questions

Is Rallybio Corporation - Common Stock publicly traded?
Yes, Rallybio Corporation - Common Stock is publicly traded.
What exchange does Rallybio Corporation - Common Stock trade on?
Rallybio Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Rallybio Corporation - Common Stock?
The ticker symbol for Rallybio Corporation - Common Stock is RLYB on the Nasdaq Stock Market
What is the current price of Rallybio Corporation - Common Stock?
The current price of Rallybio Corporation - Common Stock is 6.800
When was Rallybio Corporation - Common Stock last traded?
The last trade of Rallybio Corporation - Common Stock was at 02/26/26 04:00 PM ET
What is the market capitalization of Rallybio Corporation - Common Stock?
The market capitalization of Rallybio Corporation - Common Stock is 256.68M
How many shares of Rallybio Corporation - Common Stock are outstanding?
Rallybio Corporation - Common Stock has 257M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.